MobiHealth News May 6, 2020
The effort is looking to enroll 200,000 to 250,000 device owners, and will support clinical evaluation and regulatory submissions of the company’s PPG atrial fibrillation algorithm.
Fitbit announced this morning the launch of a new atrial fibrillation research study aiming to enroll hundreds of thousands of fitness-tracker and smartwatch owners.
Called the Fitbit Heart Study, it will passively and continuously monitor wearers’ heart rates using the devices’ photoplethysmography (PPG) sensors. A proprietary algorithm will interpret these readings and flag potential irregularities for follow-up: a free telehealth visit with a live doctor and, if needed, an ECG patch delivered through the mail to confirm the irregularity.
“The main goals are to see how well this model of healthcare – passive monitoring,...
Today's Sponsors
Today's Sponsor